7-87935182-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001324418.2(ADAM22):​c.242C>G​(p.Pro81Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.527 in 1,600,082 control chromosomes in the GnomAD database, including 230,061 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P81A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.63 ( 32682 hom., cov: 30)
Exomes 𝑓: 0.52 ( 197379 hom. )

Consequence

ADAM22
NM_001324418.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.991

Publications

32 publications found
Variant links:
Genes affected
ADAM22 (HGNC:201): (ADAM metallopeptidase domain 22) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. Unlike other members of the ADAM protein family, the protein encoded by this gene lacks metalloprotease activity since it has no zinc-binding motif. This gene is highly expressed in the brain and may function as an integrin ligand in the brain. In mice, it has been shown to be essential for correct myelination in the peripheral nervous system. Alternative splicing results in several transcript variants.[provided by RefSeq, Dec 2010]
ADAM22 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 61
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.7454687E-7).
BP6
Variant 7-87935182-C-G is Benign according to our data. Variant chr7-87935182-C-G is described in ClinVar as [Benign]. Clinvar id is 1188945.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.904 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAM22NM_001324418.2 linkc.242C>G p.Pro81Arg missense_variant Exon 2 of 32 ENST00000413139.2 NP_001311347.1 H7C3I4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAM22ENST00000413139.2 linkc.242C>G p.Pro81Arg missense_variant Exon 2 of 32 5 NM_001324418.2 ENSP00000412085.2 H7C3I4

Frequencies

GnomAD3 genomes
AF:
0.630
AC:
95658
AN:
151782
Hom.:
32609
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.912
Gnomad AMI
AF:
0.513
Gnomad AMR
AF:
0.595
Gnomad ASJ
AF:
0.571
Gnomad EAS
AF:
0.541
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.532
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.634
GnomAD2 exomes
AF:
0.537
AC:
118346
AN:
220508
AF XY:
0.523
show subpopulations
Gnomad AFR exome
AF:
0.922
Gnomad AMR exome
AF:
0.561
Gnomad ASJ exome
AF:
0.569
Gnomad EAS exome
AF:
0.551
Gnomad FIN exome
AF:
0.537
Gnomad NFE exome
AF:
0.520
Gnomad OTH exome
AF:
0.534
GnomAD4 exome
AF:
0.516
AC:
747885
AN:
1448182
Hom.:
197379
Cov.:
54
AF XY:
0.510
AC XY:
367020
AN XY:
719120
show subpopulations
African (AFR)
AF:
0.927
AC:
30876
AN:
33290
American (AMR)
AF:
0.561
AC:
24173
AN:
43060
Ashkenazi Jewish (ASJ)
AF:
0.570
AC:
14620
AN:
25644
East Asian (EAS)
AF:
0.546
AC:
21564
AN:
39478
South Asian (SAS)
AF:
0.366
AC:
31104
AN:
85046
European-Finnish (FIN)
AF:
0.536
AC:
27618
AN:
51518
Middle Eastern (MID)
AF:
0.534
AC:
2985
AN:
5590
European-Non Finnish (NFE)
AF:
0.510
AC:
563044
AN:
1104790
Other (OTH)
AF:
0.534
AC:
31901
AN:
59766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
20403
40806
61209
81612
102015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16456
32912
49368
65824
82280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.631
AC:
95797
AN:
151900
Hom.:
32682
Cov.:
30
AF XY:
0.626
AC XY:
46439
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.912
AC:
37841
AN:
41498
American (AMR)
AF:
0.595
AC:
9093
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.571
AC:
1983
AN:
3470
East Asian (EAS)
AF:
0.540
AC:
2758
AN:
5104
South Asian (SAS)
AF:
0.370
AC:
1777
AN:
4806
European-Finnish (FIN)
AF:
0.532
AC:
5610
AN:
10536
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.512
AC:
34768
AN:
67896
Other (OTH)
AF:
0.633
AC:
1334
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1558
3117
4675
6234
7792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.493
Hom.:
2674
Bravo
AF:
0.649
TwinsUK
AF:
0.502
AC:
1862
ALSPAC
AF:
0.506
AC:
1952
ESP6500AA
AF:
0.892
AC:
3375
ESP6500EA
AF:
0.516
AC:
4227
ExAC
AF:
0.527
AC:
62567
Asia WGS
AF:
0.487
AC:
1699
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 61 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.84
DANN
Benign
0.79
DEOGEN2
Benign
0.0038
.;T;T;.;T;.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0015
N
LIST_S2
Benign
0.012
T;T;T;T;T;T;T
MetaRNN
Benign
6.7e-7
T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.90
L;.;.;L;L;L;.
PhyloP100
-0.99
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.36
N;N;N;N;N;N;N
REVEL
Benign
0.020
Sift
Benign
0.67
T;T;T;T;T;T;T
Sift4G
Benign
0.70
T;T;T;T;T;T;T
Polyphen
0.0010
B;B;.;.;B;B;.
Vest4
0.032
MPC
0.53
ClinPred
0.0023
T
GERP RS
-5.3
PromoterAI
-0.027
Neutral
Varity_R
0.049
gMVP
0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2279542; hg19: chr7-87564497; COSMIC: COSV55969663; API